SFM
INBX

Signet Financial Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Signet Financial Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-908
Closed -$40K – 1486
2021
Q4 		$40K Buy
+908
New +$36.3K 0.01% 569

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Signet Financial Management's INBX Position: Q1 2022 in Review

Signet Financial Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2022, closing a stake of 908 shares — an estimated $40K sold.

Signet Financial Management first reported a position in INBX in Q4 2021 and held it in 1 quarter. The position peaked at $40K in Q4 2021. 99 funds tracked by Wall St. Rank hold INBX as of Q1 2022.

  • Signet Financial Management reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 908 Inhibrx, Inc. Common Stock shares in Q1 2022, an estimated $40K.
  • Signet Financial Management first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Signet Financial Management's Inhibrx, Inc. Common Stock position peaked at $40K in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.